pyridoxamine has been researched along with alt-946 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, N; Kurokawa, K; Miyata, T | 1 |
| Bolton, WK; Turgut, F | 1 |
2 review(s) available for pyridoxamine and alt-946
| Article | Year |
|---|---|
[Carbonyl stress inhibitor towards new therapeutic interventions in diabetic nephropathy].
Topics: Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus; Diabetic Nephropathies; Glycation End Products, Advanced; Guanidines; Humans; Hydralazine; Hydrazines; Imidazoles; Olmesartan Medoxomil; Oxidative Stress; Pyridoxamine; Tetrazoles | 2004 |
Potential new therapeutic agents for diabetic kidney disease.
Topics: Amides; Animals; Clinical Trials as Topic; Connective Tissue Growth Factor; Diabetic Nephropathies; Disease Progression; Endothelin Receptor Antagonists; Glycation End Products, Advanced; Glycosaminoglycans; Guanidines; Humans; Hydrazines; Kidney; NADPH Oxidases; Nitric Oxide Synthase; Pentoxifylline; Phosphodiesterase Inhibitors; Pyridines; Pyridoxamine; Pyrimidines; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vitamin B Complex | 2010 |